Ondansetron attenuates cisplatin-induced behavioral and cognitive impairment through downregulation of NOD-like receptor inflammasome pathway
Mennat-Allah M. Hassan, Sara A. Wahdan, Reem N. El‐Naga, Tamer M. Abdelghany, Ebtehal El‐Demerdash
Topics & Concepts
OndansetronPharmacologyMedicineNeuroprotectionReceptor antagonist5-HT3 receptorCisplatinAnesthesiaOpen fieldAntagonistEndocrinologyInternal medicineChemotherapyReceptorVomitingSerotonin5-HT receptorCancer-related cognitive impairment studiesCancer, Stress, Anesthesia, and Immune ResponseNausea and vomiting management